title: Triple-drug regimen (TDR) of AZA + CsA + P: new definition of factors influencing kidney graft survival at a single center.
authors.affiliation: Nephrological and Urological Service, Bicêtre Hôpital, University of Paris-Sud, France.
authors.forename: C
authors.initials: C
authors.lastname: Hiesse
authors.forename: P
authors.initials: P
authors.lastname: Prevost
authors.forename: M
authors.initials: M
authors.lastname: Busson
authors.forename: N
authors.initials: N
authors.lastname: Neyrat
authors.forename: O
authors.initials: O
authors.lastname: Lantz
authors.forename: M
authors.initials: M
authors.lastname: Cantarovich
authors.forename: P
authors.initials: P
authors.lastname: Rieu
authors.forename: J
authors.initials: J
authors.lastname: Bellamy
authors.forename: G
authors.initials: G
authors.lastname: Benoit
authors.forename: B
authors.initials: B
authors.lastname: Charpentier
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D002102:Cadaver; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects*; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use*; D011379:Prognosis
chemical_list: D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine